Recent Security Class Actions

Kenvue Inc. Common Stock (NYSE: KVUE)

Company Name:Kenvue Inc. Common Stock
Stock Symbol:NYSE: KVUE
Class Period Start:05/04/2023
Class Period End (inclusive):10/09/2023
Filing Deadline:12/08/2023

The Complaint alleges the Registration Statement issued in connection with Kenvue’s initial public offering contained false and/or misleading statements and/or failed to disclose that: (1) Kenvue faces potential headwinds as a result of confirmed concerns about the efficacy of phenylephrine, which it knew or should have known; (2) Kenvue did not discuss risks relating to the efficacy of phenylephrine in its IPO, the utility of which had been questioned since at least 2007; (3) while the Company disclosed risks relating to litigation, it did not disclose specific risk relating to potential litigation arising from adverse findings on the efficacy of phenylephrine; and (4) as a result, Defendants’ public statements were materially false and misleading at all relevant times and negligently prepared.